@article{8d63c033ab044beeba02bab499c7d662,
title = "Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy",
author = "Yazmin Odia and Doured Daghistani and Zuanel Diaz and Matthew Hall",
note = "Gardner, S. L., Tarapore, R. S., Allen, J., McGovern, S. L., Zaky, W., Odia, Y., Daghistani, D., Diaz, Z., Hall, M. D., Khatib, Z., Koschmann, C., Cantor, E., Kurokawa, R., MacDonald, T. J., Aguilera, D., Vitanza, N. A., Mueller, S., Kline, C., Lu, G., Allen, J. E., … Khatua, S. (2022). Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy. Neuro-oncology advances, 4(1), vdac143. https://doi.org/10.1093/noajnl/vdac143",
year = "2022",
month = sep,
day = "13",
language = "American English",
volume = "4",
journal = "Neuro-Oncology Advances",
}